|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Su ZX, Zhao J, Rong ZH, Geng WM, Wu YG and
Qin CK: Upregulation of microRNA-25 associates with prognosis in
hepatocellular carcinoma. Diagn Pathol. 9:472014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li S, Dong P, Wang J, Zhang J, Gu J, Wu X,
Wu W, Fei X, Zhang Z, Wang Y, et al: Icariin, a natural flavonol
glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via
a ROS/JNK-dependent mitochondrial pathway. Cancer Lett.
298:222–230. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhan P, Qian Q and Yu LK: Serum VEGF level
is associated with the outcome of patients with hepatocellular
carcinoma: A meta-analysis. Hepatobiliary Surg Nutr. 2:209–215.
2013.
|
|
5
|
Cao X, Zhang L, Shi Y, Sun Y, Dai S, Guo
C, Zhu F, Wang Q, Wang J, Wang X, et al: Human tumor necrosis
factor (TNF)-alpha-induced protein 8-like 2 suppresses
hepatocellular carcinoma metastasis through inhibiting Rac1. Mol
Cancer. 12:1492013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miyahara K, Nouso K, Morimoto Y, Takeuchi
Y, Hagihara H, Kuwaki K, Onishi H, Ikeda F, Miyake Y, Nakamura S,
et al Okayama Liver Cancer Group: Pro-angiogenic cytokines for
prediction of outcomes in patients with advanced hepatocellular
carcinoma. Br J Cancer. 109:2072–2078. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Duong T, Koltowska K, Pichol-Thievend C,
Le Guen L, Fontaine F, Smith KA, Truong V, Skoczylas R, Stacker SA,
Achen MG, et al: VEGFD regulates blood vascular development by
modulating SOX18 activity. Blood. 123:1102–1112. 2014. View Article : Google Scholar
|
|
8
|
Ryzhov S, Biktasova A, Goldstein AE, Zhang
Q, Biaggioni I, Dikov MM and Feoktistov I: Role of JunB in
adenosine A2B receptor-mediated vascular endothelial growth factor
production. Mol Pharmacol. 85:62–73. 2014. View Article : Google Scholar :
|
|
9
|
Yao HC, Liu T, Meng XY, Han QF, Zhang M
and Wang LX: Effect of basic fibroblast growth factor on the
myocardial expression of hypoxia-inducible factor-1α and vascular
endothelial growth factor following acute myocardial infarction.
Heart Lung Circ. 22:946–951. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cui QT, Li Y, Duan CH, Zhang W and Guo XL:
Further evidence for the contribution of the vascular endothelial
growth factor gene in coronary artery disease susceptibility. Gene.
521:217–221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Winnik S, Lohmann C, Siciliani G, von
Lukowicz T, Kuschnerus K, Kraenkel N, Brokopp CE, Enseleit F,
Michels S, Ruschitzka F, et al: Systemic VEGF inhibition
accelerates experimental atherosclerosis and disrupts endothelial
homeostasis - implications for cardiovascular safety. Int J
Cardiol. 168:2453–2461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lo TF, Tsai WC and Chen ST:
MicroRNA-21-3p, a berberine-induced miRNA, directly down-regulates
human methionine adenosyltransferases 2A and 2B and inhibits
hepatoma cell growth. PLoS One. 8:e756282013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li BA: A novel tumor suppressor miRNA
miR-520e contributes to suppression of hepatoma. Acta Pharmacol
Sin. 33:3–4. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Iorio MV and Croce CM: microRNA
involvement in human cancer. Carcinogenesis. 33:1126–1133. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shi XE, Li YF, Jia L, Ji HL, Song ZY,
Cheng J, Wu GF, Song CC, Zhang QL, Zhu JY, et al: MicroRNA-199a-5p
affects porcine preadipocyte proliferation and differentiation. Int
J Mol Sci. 15:8526–8538. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dai BH, Geng L, Wang Y, Sui CJ, Xie F,
Shen RX, Shen WF and Yang JM: microRNA-199a-5p protects hepatocytes
from bile acid-induced sustained endoplasmic reticulum stress. Cell
Death Dis. 4:e6042013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen Q, Cicinnati VR, Zhang X, Iacob S,
Weber F, Sotiropoulos GC, Radtke A, Lu M, Paul A, Gerken G, et al:
Role of microRNA-199a-5p and discoidin domain receptor 1 in human
hepatocellular carcinoma invasion. Mol Cancer. 9:2272010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hsu CY, Hsieh TH, Tsai CF, Tsai HP, Chen
HS, Chang Y, Chuang HY, Lee JN, Hsu YL and Tsai EM: miRNA-199a-5p
regulates VEGFA in endometrial mesenchymal stem cells and
contributes to the pathogenesis of endometriosis. J Pathol.
232:330–343. 2014. View Article : Google Scholar
|
|
20
|
Gui R, Li D, Qi G, Suhad A and Nie X:
Inhibition of Grb2-mediated activation of MAPK signal transduction
suppresses NOR1/CB1954-induced cytotoxicity in the HepG2 cell line.
Oncol Lett. 4:566–570. 2012.
|
|
21
|
Cai J, Yang C, Yang Q, Ding H, Jia J, Guo
J, Wang J and Wang Z: Deregulation of let-7e in epithelial ovarian
cancer promotes the development of resistance to cisplatin.
Oncogenesis. 2:e752013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Goel HL and Mercurio AM: VEGF targets the
tumour cell. Nat Rev Cancer. 13:871–882. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nie X, Zhang B, Li X, Xiang J, Xiao B, Ma
J, Zhou M, Zhu S, Lu H, Gui R, et al: Cloning, expression, and
mutation analysis of NOR1, a novel human gene down-regulated in
HNE1 naso-pharyngeal carcinoma cell line. J Cancer Res Clin Oncol.
129:410–414. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lino Cardenas CL, Henaoui IS, Courcot E,
Roderburg C, Cauffiez C, Aubert S, Copin MC, Wallaert B, Glowacki
F, Dewaeles E, et al: miR-199a-5p Is upregulated during fibrogenic
response to tissue injury and mediates TGFbeta-induced lung
fibroblast activation by targeting caveolin-1. PLoS Genet.
9:e10032912013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ogawa T, Enomoto M, Fujii H, Sekiya Y,
Yoshizato K, Ikeda K and Kawada N: MicroRNA-221/222 upregulation
indicates the activation of stellate cells and the progression of
liver fibrosis. Gut. 61:1600–1609. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sayed D and Abdellatif M: AKT-ing via
microRNA. Cell Cycle. 9:3213–3217. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Magrelli A, Azzalin G, Salvatore M,
Viganotti M, Tosto F, Colombo T, Devito R, Di Masi A, Antoccia A,
Lorenzetti S, et al: Altered microRNA expression patterns in
hepatoblastoma patients. Transl Oncol. 2:157–163. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pencheva N, Tran H, Buss C, Huh D,
Drobnjak M, Busam K and Tavazoie SF: Convergent multi-miRNA
targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis
and angiogenesis. Cell. 151:1068–1082. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheung HH, Davis AJ, Lee TL, Pang AL,
Nagrani S, Rennert OM and Chan WY: Methylation of an intronic
region regulates miR-199a in testicular tumor malignancy. Oncogene.
30:3404–3415. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang F, Zheng Z, Guo J and Ding X:
Correlation and quantitation of microRNA aberrant expression in
tissues and sera from patients with breast tumor. Gynecol Oncol.
119:586–593. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Augustin R, Endres K, Reinhardt S, Kuhn
PH, Lichtenthaler SF, Hansen J, Wurst W and Trümbach D:
Computational identification and experimental validation of
microRNAs binding to the Alzheimer-related gene ADAM10. BMC Med
Genet. 13:352012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Scherr M, Venturini L and Eder M:
Lentiviral vector-mediated expression of pre-miRNAs and antagomiRs.
Methods Mol Biol. 614:175–185. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zeng Z, Zhou Y, Xiong W, Luo X, Zhang W,
Li X, Fan S, Cao L, Tang K, Wu M, et al: Analysis of gene
expression identifies candidate molecular markers in nasopharyngeal
carcinoma using microdissection and cDNA microarray. J Cancer Res
Clin Oncol. 133:71–81. 2007. View Article : Google Scholar
|
|
34
|
Li W, Li X, Wang W, Li X, Tan Y, Yi M,
Yang J, McCarthy JB, Xiong W, Wu M, et al: NOR1 is an HSF1- and
NRF1-regulated putative tumor suppressor inactivated by promoter
hyper-methylation in nasopharyngeal carcinoma. Carcinogenesis.
32:1305–1314. 2011. View Article : Google Scholar : PubMed/NCBI
|
